Wang J, Jiang B, Li J, Liu L, et al. Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. Leukemia 2024 Sep 5. doi: 10.1038/s41375-024-02382.
PMID: 39237634